Bridgewater, New Jersey – February 18, 2016: Nipro North America, a division of Nipro Medical Corporation, announced the launch of the AQUALiner II 0.035” second generation hydrophilic, super-elastic Nitinol guidewire. The guidewire enables the operator to navigate through complex lesions and deliver interventional devices such as balloons and stents. The reengineered AQUALiner II is the enhanced second generation guidewire offering in Nipro’s Interventional Division.
AQUALiner II’s improved, kink-resistant Nitinol core provides the control needed to navigate the vasculature by absorbing strain and maintaining strength. The super-elasticity of AQUALiner II’s core wire conforms to the patient’s vasculature and provides excellent support for interventional devices.
The guidewire’s hydrophilic coating delivers the durability required to maintain lubricity throughout the procedure even through multiple passes. AQUALiner II also delivers excellent tactile feel, pushability and trackability even in the most challenging anatomy.
The chemically-engineered tip delivers a smooth, atraumatic insertion and navigation through vessels. Minimal force is required, allowing for better steerability and control. The tapered tip also provides optimal stability, while still maintaining a flexible soft taper.
“Nipro is continuously looking for ways to innovate and improve their product offering. Our end goal is to always offer safe, easy to use products for the healthcare professional to improve the quality of life of the patient”, said Joe Dawson, Senior Vice President of Nipro, North America.
AQUALiner II is available in various lengths, ranging from 150cm to 260cm, with a regular or stiff-configured wire and with a straight or angled tip.
About Nipro Medical
Nipro Medical Corporation is a world-leading manufacturer of medical devices. The Company is committed to educating customers and delivering innovative, high quality and value-added solutions to improve patient care. Nipro Medical Corporation is a wholly-owned subsidiary of Nipro Corporation, headquartered in Osaka, Japan.
Director of Marketing
Nipro Medical Corporation, North America Division
- 02 Nov 2017Nipro Medical Corporation Launches the Cellentia®-H Cellulose Triacetate (CTA), Single-Use Dialyzer at the 2017 ASN Kidney Week Conference
- 22 Apr 2016NIPRO MEDICAL CORPORATION LAUNCHES THE SAFETOUCH™ SAFETY NEEDLE
- 18 Feb 2016NIPRO MEDICAL CORPORATION LAUNCHES THE AQUALINER II SECOND GENERATION 0.035” HYDROPHILIC, SUPER-ELASTIC NITINOL GUIDEWIRE IN THE UNITED STATES
- 09 Jul 2015NIPRO MEDICAL CORPORATION INTRODUCES NIPRO VSMART™ SYRINGES AT THE 2015 AMERICAN VETERINARY MEDICAL ASSOCIATION CONVENTION